DUBLIN, July 14, 2015 /PRNewswire/ -- Research and Markets (http://www.researchandmarkets.com/research/v2pb47/us_market_for) has announced the addition of the "US Market for Bone Graft Substitutes 2011-2021" report to their offering.
The bone graft substitute market consists of allograft, demineralized bone matrix and synthetic materials. Bone grafts are used in a variety of indications including spinal fusion, trauma, large joint reconstruction, foot reconstruction, as well as craniomaxillofacial and oncological applications.
The bone graft substitute market competes with both the growth factor market, which is currently only comprises INFUSE®, and the stem cell graft market. Due to the declining usage of INFUSE®, the use of bone graft substitute use has increased.
The rise of cell therapy products, including platelet-rich-plasma and bone marrow concentrate, has also aided the growth of the bone graft substitute market, especially in the segments for demineralized bone matrices and synthetic grafts.
Platelet-rich plasma provides growth factors when a graft is soaked in it; bone marrow concentrate provides stem cells. This complementary use allows bone graft substitutes to better compete with the growth factors and stem cell grafts.
Key Topics Covered:
1. Research Methodology
2. Orthopedic Bone Graft Substitute Market
2.2 Market Segmentation
2.3 Procedure Numbers
2.4 Market Overview
2.5 Market Analysis And Forecast
2.6 Drivers And Limiters
2.7 Competitive Analysis
- Alphatec Spine
- Bacterin International
- DePuy Synthes
- Integra LifeSciences
- LifeNet Health
- RTI Surgical
- Wright Medical
For more information visit http://www.researchandmarkets.com/research/v2pb47/us_market_for
Laura Wood, +353-1-481-1716, email@example.com
SOURCE Research and Markets